We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Aalto Bio Reagents Ltd. announced that its Sars-CoV-2 n-s1-S2 antigens, Lysis buffers and Viral transport media are part of assays that are being run in Europe and the U.S. ...